Skip to main content
Top

Advances in Therapy

Issue 5/2025

Content (34 Articles)

Summary of Research: Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02

Ana Oaknin, Jung-Yun Lee, Vicky Makker, Do-Youn Oh, Susana Banerjee, Antonio González-Martín, Kyung Hae Jung, Iwona Ługowska, Luis Manso, Aránzazu Manzano, Bohuslav Melichar, Salvatore Siena, Daniil Stroyakovskiy, Anitra Fielding, Soham Puvvada, Ann Smith, Funda Meric-Bernstam

Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Adults with Underlying Medical Conditions: Systematic Literature Review and Pairwise Meta-Analysis Using GRADE

Xuan Wang, Ankit Pahwa, Mary T. Bausch-Jurken, Anushri Chitkara, Pawana Sharma, Mia Malmenäs, Sonam Vats, Michael Gordon Whitfield, Kira Zhi Hua Lai, Priyadarsini Dasari, Ritu Gupta, Maria Nassim, Nicolas Van de Velde, Nathan Green, Ekkehard Beck

Targeting PACAP: Beyond Migraine to Cluster, Menstrual, and Post-traumatic Headaches

Lanfranco Pellesi, Mona Ameri Chalmer, Song Guo, Thien Phu Do, Zheman Xiao, Paolo Martelletti

Prevention and Treatment of Intraoperative Complications During Gynecological Laparoscopic Surgery: Practical Tips and Tricks—A Narrative Review

Matteo Giorgi, Giorgia Schettini, Luca La banca, Alberto Cannoni, Alessandro Ginetti, Irene Colombi, Nassir Habib, Ramon Rovira, Francesco Martire, Lucia Lazzeri, Errico Zupi, Gabriele Centini

Management of Atherosclerotic Cardiovascular Risk in Inflammatory Bowel Disease: Current Perspectives

Walter Masson, Gonzalo Fernández-Villar, Solange Martinez-Elhelou

A Multicenter Single-Arm Study of Switching to Ferric Citrate Hydrate for Iron Deficiency Anemia in Patients Intolerant to Oral Iron: RIO-SWITCH

Osamu Wada-Hiraike, Aya Maruyama, Yuko Mitobe, Takayuki Iriyama, Mayuyo Mori-Uchino, Yutaka Osuga

Safety of iGlarLixi in Japanese People with Type 2 Diabetes: A Post-marketing Database Study

Hideaki Kaneto, Makiko Hatanaka, Yukiko Morimoto, Yoko Takahashi, Yasuo Terauchi

Burden of Comorbidities and Concomitant Medications and Their Associated Costs in Patients with Gastroenteropancreatic or Lung Neuroendocrine Tumors: Analysis of US Administrative Data

Jennifer A. Chan, Antonio Ribeiro-Oliveira Jr., Aude Houchard, Syvart Dennen, Yutong Liu, Sai Sriteja Boppudi Naga, Yajin Zhao, Christelle Pommie, Timon Vandamme, Jason Starr

Falls and Fractures in Patients with Geographic Atrophy: A US Claims Data Analysis

Allen Hu, Rachel E. Teneralli, Rachelle Rodriguez, Alyshah Abdul Sultan, Colleen Garey, Jessica Ackert, Rose Ong

First-Line Tislelizumab Plus Chemotherapy for Advanced Gastric Cancer with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-305

Markus Moehler, Do-Youn Oh, Ken Kato, Tobias Arkenau, Josep Tabernero, Keun-Wook Lee, Sun Young Rha, Hidekazu Hirano, David Spigel, Kensei Yamaguchi, Lucjan Wyrwicz, Umut Disel, Roberto A. Pazo-Cid, Lorenzo Fornaro, Yaling Xu, Tao Sheng, Silu Yang, Alysha Kadva, Marcia Cruz-Correa, Rui-Hua Xu

First-Line Tislelizumab Plus Chemotherapy for Esophageal Squamous Cell Carcinoma with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-306

Jianming Xu, Ken Kato, Richard Hubner, Sook Ryun Park, Takashi Kojima, Ryu Ishihara, Lucjan Wyrwicz, Eric Van Cutsem, Paula Jimenez-Fonseca, Hongqian Wu, Lei Wang, Sebastian Yan, Jingwen Shi, Alysha Kadva, Harry H. Yoon

Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Cefiderocol in Chinese Healthy Subjects

Chuhan Zhang, Shuyan Yu, Size Li, Xiaojie Wu, Qiong Wei, Jinjie He, Guoying Cao, Haijing Yang, Jingjing Wang, Kohei Fujitani, Takayuki Katsube, Jing Zhang, Honghong Dou

Single-Tablet Combination Therapy of Macitentan/Tadalafil for Patients with Pulmonary Arterial Hypertension: Qualitative Interview Study of the A DUE Phase 3 Trial

Fenling Fan, Stacy Davis, Claire Burbridge, Kelly Chin, Michael Friberg, Ekkehard Grünig, Melanie Hughes, Pavel Jansa, Jörg Linder, Jennifer Rafalski, Alvaro Agustin Rodriguez, Jason A. Randall

A Noninterventional, Cross-Sectional Study to Assess Patient Prostate Cancer Treatment Preferences and Experiences in Europe

Emmanuelle Kaltenbach, Ana Maria Rodriguez-Leboeuf, Patrick Cabri, Mickael Henry-Szatkowski, Mehmet Inceer, Emma Karim, Valérie Perrot, Giuseppe Fallara, Matteo Ferro

A Real-World Study on the Use, Effectiveness, and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression: INTEGRATE Study

Patricio Molero, Angela Ibañez, Javier de Diego-Adeliño, J. Antoni Ramos-Quiroga, Marta García Dorado, Paola M. López Rengel, Pilar A. Saiz

An Up-to-Date Description of the Use of Non-steroidal Anti-inflammatory Drugs (NSAIDs) in Italy: Evidence from Real Clinical Practice

Valentina Perrone, Chiara Veronesi, Maria Ciappetta, Domenico Lucatelli, Andrea Cinti Luciani, Luca Degli Esposti

Pharmacokinetic Comparability and Safety Between Original and Citrate-Free Mirikizumab Formulations for Subcutaneous Injections: Results from Three Clinical Trials

Yuki Otani, Brian G. Feagan, Geert R. D’Haens, Rodrigo Escobar, Nathan J. Morris, Christopher D. Payne, Michelle Ugolini Lopes, Xin Zhang

Point of Care Nucleic Acid Testing for Influenza-Like Illness: A Cost–Consequence Analysis for High-Risk Patients in Primary Care in Germany

Johannes Pöhlmann, Anika Joecker, Tanja Wittki, Tray Brown, Richard F. Pollock, Jordan Chase

Real-World Evidence for Baricitinib in the Treatment of Rheumatoid Arthritis in Spain: A Systematic Literature Review

José Rosas, Joaquín Belzunegui, Blanca Hernández-Cruz, Itxaso Aguirregabiria, Sebastián Moyano, Amelia Cobo, Silvia Díaz-Cerezo

Mobility and Quality of Life in Adults with Paediatric-Onset Hypophosphatasia Treated with Asfotase Alfa: Results from UK Managed Access Agreement

Katie E. Moss, Richard Keen, Shona Fang, Alexandros Zygouras, Muhammad K. Javaid, Tarekegn Geberhiwot, Kenneth E. S. Poole, Peter Selby, Jennifer S. Walsh, Judith S. Bubbear

Loncastuximab Tesirine Versus Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory DLBCL After ≥ 2 Lines of Therapy: Matching-Adjusted Indirect Comparison

Koo Wilson, Francesca Chiodi, Abby Paine, Zalmai Hakimi, Victoria Ward, Tom Macmillan, Daniel Eriksson, Silvia Mappa

Evinacumab for Homozygous Familial Hypercholesterolemia: The Italian Cohort of the ELIPSE HoFH Study

  • Open Access
  • Original Research

Gabriella Iannuzzo, Ilenia Calcaterra, Marco Gentile, Claudia Stanzione, Francesca De Ruberto, Maria Donata Di Taranto, Giuliana Fortunato, Matteo Di Minno

Pembrolizumab in Patients of Chinese Descent with Microsatellite Instability-high/Mismatch Repair Deficient Advanced Solid Tumors: KEYNOTE-158 Final Analysis

Xiaohua Wu, Yimin Mao, Nong Xu, Yuxian Bai, Dong Wang, Xiaojun Chen, Xianli Yin, Yanhong Deng, Jianwei Yang, Jieqing Zhang, Jie Tang, Yi Huang, Jiayi Li, Suxia Luo, Hong Zheng, Weidong Zhao, Miaomiao Xu, Nan Li, Yixiang Mao, Alexander Gozman, Jianming Xu

Impact of Different Definitions of Vaso-Occlusion on Efficacy Assessments in Sickle Cell Disease Clinical Trials

Haydar Frangoul, Franco Locatelli, Michael J. Eckrich, Suzan Imren, Nanxin Li, Fengjuan Xuan, Stephan A. Grupp

Healthcare Utilization and Costs of Care in Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation After Initiating Oral Therapies: Real-World Analysis in the US Medicare Population

Eric Shah, Tsung-Ying Lee, Zachary Baldwin, Jens Kort, Masakazu Ando, Steven W. Champaloux, Mena Boules, Yuri Sanchez Gonzalez

The Composite Number Needed to Treat for Semaglutide in Populations with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes

Christopher Lübker, Jigish Bhavsar, Ruben Duque do Vale, Scott S. Emerson, Emil Nørtoft, Jorge Plutzky, Geraint Roberts, Jens Magelund Tarp, A. Michael Lincoff

Fertility Outcomes in Risdiplam-Treated Male Patients with Spinal Muscular Atrophy: A Multicenter Case Series

Shelley Coskery, Marcus Erdler, Margaret R. Frey, Michael A. Lopez

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar